Guzmán-Calderón Edson, Chacaltana Alfonso, Díaz-Arocutipa Carlos, Díaz Ramiro, Arcana Ronald, Ramón Aparicio José
Gastroenterology Unit, Hospital Nacional "Edgardo Rebagliati Martins", Lima, Peru; Universidad Peruana de Ciencias Aplicadas (UPC); Gastroenterology Unit of Clínica Angloamericana, Lima, Peru.
Gastroenterology Unit, Hospital Nacional "Edgardo Rebagliati Martins", Lima, Peru.
Rev Gastroenterol Peru. 2022 Jul-Sep;42(3):163-170.
Occasionally, cholecystectomy is not possible because the patient is not suitable for surgery, and non-operative management should be performed. In these patients, the non-operative management can be through the percutaneous transhepatic gallbladder drainage (PTGBD) or the endoscopic gallbladder drainage. We decided to compare the efficacy and safety of PTGBD and EUS-GBD in the non-operative management of patients with acute cholecystitis. We conducted a systematic review in different databases, such as PubMed, OVID, Medline, and Cochrane Databases. This meta-analysis considers studies published until September 2021. Six studies were selected (2 RCTs). These studies included 749 patients. The mean age was 72.81 ±7.41 years, and males represented 57.4%. EUS-GBD technical success was lower than PTGBD (RR, 0.97; 95% CI, 0.95-0.99), whereas clinical success and adverse events rates were similar in both groups. Twenty-one deaths were reported in all six studies. The global mortality rate was 2.80%, without differences in both groups (2.84% and 2.77% in the EUS-GBD group and the PTGBD groups, respectively). EUS-GBD and PTGBD were successful techniques for gallbladder drainage in patients with acute cholecystitis who are non-tributary for surgery. EUS-GBD has a similar clinical success rate and a similar adverse events rate in comparison to PTGBD. The high technical success and the low adverse events rate of the EUS approach to gallbladder make this technique an excellent alternative for patients with acute cholecystitis who cannot be undergoing surgery.
有时,由于患者不适合手术,无法进行胆囊切除术,应采取非手术治疗。对于这些患者,非手术治疗可通过经皮经肝胆囊引流术(PTGBD)或内镜下胆囊引流术进行。我们决定比较PTGBD和内镜超声引导下胆囊引流术(EUS-GBD)在急性胆囊炎患者非手术治疗中的疗效和安全性。我们在不同数据库(如PubMed、OVID、Medline和Cochrane数据库)中进行了系统评价。这项荟萃分析纳入了截至2021年9月发表的研究。共筛选出6项研究(2项随机对照试验)。这些研究共纳入749例患者。平均年龄为72.81±7.41岁,男性占57.4%。EUS-GBD的技术成功率低于PTGBD(相对危险度,0.97;95%置信区间,0.95-0.99),而两组的临床成功率和不良事件发生率相似。所有6项研究共报告21例死亡。总体死亡率为2.80%,两组无差异(EUS-GBD组和PTGBD组分别为2.84%和2.77%)。EUS-GBD和PTGBD是急性胆囊炎手术禁忌患者胆囊引流的成功技术。与PTGBD相比,EUS-GBD的临床成功率和不良事件发生率相似。EUS治疗胆囊的高技术成功率和低不良事件发生率使其成为无法接受手术的急性胆囊炎患者的极佳替代方案。